Respiratory adverse events
Conditions
Interventions
Group A (propofol group):Induction and maintenance of sedation with propofol
Group C (ramizolam combined with propofol group):Inducing and maintaining the sedation with Rimazzolam combined with propofol.
Group B (ramizolam):Induction and maintenance of sedation with Rimazzolam
Sponsors
The First Affiliated Hospital of Chongqing Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Patients who intend to undergo elective bronchoscopy under general anesthesia; 2.Age > 18 years old, male or female; 3.ASA classification I ~ III; 4.Clearly understand and voluntarily participate in the study, and sign the informed consent form by himself.
Exclusion criteria
Exclusion criteria: 1. Complicated with serious heart, lung and brain diseases, such as uncontrolled hypertension, coronary heart disease and intracranial vascular malformation; 2. Patients who use benzodiazepines for a long time; 3. People with hearing, intelligence, communication and cognitive impairment; 4. Patients who are known to be allergic to all kinds of drug ingredients expected to be used and who are banned from all kinds of drugs; 5. Patients who have used drugs that have obvious effects on the central nervous system in the past 3 months, or who have hearing impairment or epilepsy; 6. Pregnant women; 7. Patients who are participating in any interventional clinical trial; 8. Patients who are unable to cooperate with the study for any reason or who the researcher thinks are not suitable to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Perioperative incidence of hypoxemia; | — |
Countries
China
Contacts
Public ContactWei Ke
The First Affiliated Hospital of Chongqing Medical University
Outcome results
None listed